--> For Health Checks

Evidence Series | Resource Hub

Evidence-Mock-Up-APR21

Evidence

Investigator-Mock-Up-APR21

Evidence Investigator

MultiSTAT-Mock-Up-APR21

Evidence MultiSTAT

Evidence+Mock-Up-APR21

Evidence+

Evo-Mock-Up-APR21

Evidence Evolution

Biochip Technology

Biochip Technology Explained

Evidence series Overview

Discover more about the Evidence series

A4,/,A5,Flyer,Blank,White

Cytokines Flyer

A4,/,A5,Flyer,Blank,White

DIKI Renal Flyer

A4,/,A5,Flyer,Blank,White

A4 Renal Flyer

A4,/,A5,Flyer,Blank,White

AKI Covid-19 Flyer

Evidence Investigator - Molecular Diagnostic Testing

Evidence MultiSTAT Demonstration

Evidence Evolution - World's Most Advanced Immunoanalyser

Evidence Investigator - Myco 9 Array, Step By Step

Acute Kidney Injury and Antimicrobial Stewardship

on 02 October 2023

Acute Kidney Injury and Antimicrobial Stewardship

on 02 October 2023

National STIQ Day 2022

on 14 January 2022

National STIQ Day 2022

on 14 January 2022

Why are Neutralising Antibody tests important now?

on 27 October 2021

Why are Neutralising Antibody tests important now?

on 27 October 2021

SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper

on 21 September 2021

SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper

on 21 September 2021

Evidence Investigator: One Analyser for Multiple Food Testing Industries

on 28 September 2020

Evidence Investigator: One Analyser for Multiple Food Testing Industries

on 28 September 2020

Hospitals in Wuhan and Guangzhou roll out new coronavirus test developed by Randox scientists

on 02 March 2020

Hospitals in Wuhan and Guangzhou roll out new coronavirus test developed by Randox scientists

on 02 March 2020

Alzheimer’s Disease testing on the Randox Evidence Series

Alzheimer’s Disease testing on the Randox Evidence Series

Kidney Testing on the Randox Biosciences Evidence Series

on 21 March 2019

Kidney Testing on the Randox Biosciences Evidence Series

on 21 March 2019

Screenshot (8)

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS DETECTION OF CANCER BIOMARKERS ON THE RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

Screenshot (10)

DEVELOPMENT OF A DUPLEX BIOCHIP ASSAY FOR THE SIMULTANEOUS DETECTION OF ANTI-THYROGLOBULIN AND ANTI-THYROID PEROXIDASE ANTIBODIES ON THE FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

Screenshot (12)

DEVELOPMENT OF NEW BIOCHIP ARRAYS FOR THE DETERMINATION OF BIOMARKERS RELATED TO ACUTE KIDNEY INJURY APPLIED TO THE EVIDENCE INVESTIGATOR ANALYSER

Screenshot (14)

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE DETECTION OF PARATHYROID HORMONE APPLIED TO THE EVIDENCE EVOLUTION ANALYSER

Screenshot (28)

DEVELOPMENT OF A HIGHLY MULTIPLEXED MOLECULAR ASSAY FOR DETECTION OF INFECTION IN CF AIRWAYS

Screenshot (26)

Repeatability and within-laboratory precision were assessed (n=80): Assay Repeatability Within-laboratory precision CV (%) CV (%) VCAM-1 4.5 6.8 ICAM-1 5.6 8.8 ESEL 12.8 16.6 PSEL 3.5 4.7 LSEL 5.7 8.2 17.096, 097.105RDRT DEVELOPMENT OF A BIOCHIP ARRAY FOR THE DETECTION OF ADHESION MOLECULES ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

Screenshot (32)

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY UNAFFECTED BY DHEA-S INTERFERENCE FOR THE ACCURATE MEASUREMENT OF SERUM PROGESTERONE

Screenshot (22)

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE RAPID, SIMULTANEOUS DETECTION OF PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17, ON THE NEW RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

Screenshot (16)

CLINICAL EVALUATION OF A RAPID FULLY-AUTOMATED MULTIPLEX BIOCHIP ARRAY FOR STROKE DIAGNOSIS

Screenshot (51)

DEVELOPMENT OF A NEW BIOCHIP ARRAY APPLIED TO THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER FOR THE SIMULTANEOUS MEASUREMENT OF TSH, FREE T4 AND FREE T3

Screenshot (53)

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE MEASUREMENT OF TOTAL 25-HYDROXYVITAMIN D IN SERUM AND THE ACCURATE CLASSIFICATION OF VITAMIN D STATUS

Screenshot (34)

DEVELOPMENT OF A BIOCHIP ASSAY FOR THE DETECTION OF THYROXINE-BINDING GLOBULIN (TBG) ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

Screenshot (36)

GENETIC DIAGNOSIS OF MONOGENIC OR POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA IN NORTHERN IRELAND: EVALUATION OF THE RANDOX FH ARRAYS IN COMBINATION WITH THE RANDOX 6SNP POLYGENIC HYPERCHOLESTEROLEMIA ARRAY

Screenshot (57)

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS MEASUREMENT OF DISTINCT FATTY ACID-BINDING PROTEINS (FABPs)

Screenshot (40)

DEVELOPMENT OF A NEW ENZYME-LINKED IMMUNOSORBENT ASSAY KIT TO DETECT NGAL IN HUMAN SERUM AND ITS APPLICATION TO CHRONIC KIDNEY DISEASE

Screenshot (55)

SCREENING AND SELECTION OF ANTIBODIES FOR THE DETECTION OF MIP-1 ALPHA AND ITS APPLICATION TO THE STUDY OF CHRONIC KIDNEY DISEASE

Screenshot (44)

DEVELOPMENT OF A 4-PLEX BIOCHIP ARRAY FOR THE EARLY DETECTION OF CHRONIC KIDNEY DISEASE

Screenshot (46)

DEVELOPMENT OF A THIRD GENERATION TSH ASSAY ON THE NEW RANDOM ACCESS EVIDENCE EVOLUTION FULLY AUTOMATED BIOCHIP ANALYSER

Screenshot (47)

APPLICATION OF THE NEW RANDOM ACCESS, FULLY AUTOMATED BIOCHIP ANALYSER EVIDENCE EVOLUTION TO SIMULTANEOUSLY MEASURE ANALYTES RELATED TO ENDOCRINE FUNCTION

STRATIFYING RISK OF ACUTE KIDNEY INJURY IN PRE AND POST CARDIAC SURGERY PATIENTS USING A NOVEL BIOMARKER-BASED ALGORITHM AND CLINICAL RISK SCORE

Evidence Resource Page Image

SARS-CoV-2 Vascular & Multi-System Dysfunction

AKI&AMS

Acute Kidney Injury and Antimicrobial Stewardship

Copyright © Randox Laboratories Ltd. All rights Reserved. VAT number: GB 151682708
Product availability may vary from country to country. Some products may be for Research Use Only. For more information on product application and availability, please contact your local Randox Representative.

Languages: Chinese | Korean | Polish